Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-04-06

FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's generic combination of losartan potassium and hydrochlorothiazide for hypertension under ANDA 077157.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan potassium and hydrochlorothiazide (losartan potassium and hydrochlorothiazide)

Snippet

ORIG AP for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)